Published in JCI Insight on October 20, 2016
Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients. PLoS One (2017) 0.77
Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis. Arthritis Res Ther (2017) 0.75
Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med (2003) 9.78
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Cystic fibrosis. Lancet (2009) 5.40
Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol (2006) 4.47
NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med (2013) 3.70
Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol (2012) 3.39
Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum (2011) 2.74
Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem (1993) 2.57
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol (2012) 2.50
Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem (1989) 2.29
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol (2002) 2.21
Risk of death in cystic fibrosis patients with severely compromised lung function. Chest (1998) 2.03
Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis (2014) 1.92
State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir Res (2003) 1.86
The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator. Infect Immun (2007) 1.78
Neutrophil extracellular traps: how to generate and visualize them. J Vis Exp (2010) 1.77
Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet (2014) 1.70
Airway inflammation in cystic fibrosis. Chest (2008) 1.70
Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol (2011) 1.67
NET balancing: a problem in inflammatory lung diseases. Front Immunol (2013) 1.61
Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum (2009) 1.60
Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One (2011) 1.58
Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol (2002) 1.58
Neutrophils in cystic fibrosis. Thorax (2009) 1.51
The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47
Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol (2009) 1.44
Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells. Am J Physiol Cell Physiol (2005) 1.41
Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect Immun (1993) 1.40
Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation. ISME J (2014) 1.38
Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol (2014) 1.38
Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis (2013) 1.37
CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection. Curr Opin Microbiol (2002) 1.29
Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J (2013) 1.27
Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull (2002) 1.27
Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides. Electrophoresis (2010) 1.22
The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol (2010) 1.21
Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat Rev Rheumatol (2014) 1.18
Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med (2006) 1.16
Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs (2010) 1.12
Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. Arthritis Res Ther (2015) 1.11
Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor. J Innate Immun (2014) 1.06
The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol (1998) 1.06
Immune responses in cystic fibrosis: are they intrinsically defective? Am J Respir Cell Mol Biol (2012) 1.06
Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther (2013) 1.05
Targeting neutrophil elastase in cystic fibrosis. Expert Opin Ther Targets (2008) 1.00
Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol (2007) 1.00
New insights into pulmonary inflammation in cystic fibrosis. Arch Dis Child (2006) 1.00
The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst Fibros (2002) 0.99
Mucolytics in cystic fibrosis. Paediatr Respir Rev (2007) 0.99
Limited cleavage of human immunoglobulins by elastase of human neutrophil polymorphonuclear granulocytes. Possible modulator of immune complex disease. Lab Invest (1978) 0.98
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis (2015) 0.93
The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis. Arthritis Res Ther (2015) 0.92
Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med (2011) 0.92
Disease modifying genes in cystic fibrosis. J Cyst Fibros (2005) 0.91
A novel role for the bactericidal/permeability increasing protein in interactions of gram-negative bacterial outer membrane blebs with dendritic cells. J Immunol (2007) 0.90
From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev (2006) 0.88
Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity. Ann Rheum Dis (2015) 0.88
Does NETosis Contribute to the Bacterial Pathoadaptation in Cystic Fibrosis? Front Immunol (2014) 0.87
Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis. Front Immunol (2015) 0.87
Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol (1999) 0.86
The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies. J Leukoc Biol (2001) 0.86
Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses. Sci Adv (2015) 0.83
Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis. J Autoimmun (1998) 0.83
Links between Anr and Quorum Sensing in Pseudomonas aeruginosa Biofilms. J Bacteriol (2015) 0.82
Hypergammaglobulinemia in cystic fibrosis. Role of Pseudomonas endobronchial infection. Chest (1987) 0.82
Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect Immun (2006) 0.81
Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction. Mediators Inflamm (2015) 0.81
Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin. Rheumatol Int (2000) 0.79
Innate and Adaptive Immunity in Cystic Fibrosis. Clin Chest Med (2015) 0.79
Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both? Thorax (2010) 0.78
Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis. J Rheumatol (2015) 0.78
NETs and CF Lung Disease: Current Status and Future Prospects. Antibiotics (Basel) (2015) 0.77
ANCA against the bactericidal/permeability increasing protein (BPI-ANCA) can compromise the antibiotic function of BPI in a Wegener's granulomatosis patient. Clin Exp Rheumatol (2004) 0.76
The lung may play a role in the pathogenesis of rheumatoid arthritis. Int J Clin Rheumtol (2015) 0.76
HLA determinants in families with more than one member with cystic fibrosis. J Pediatr (1979) 0.76
Anti-neutrophil cytoplasmic autoantibodies against bactericidal/permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement. Mod Rheumatol (2010) 0.75